98 related articles for article (PubMed ID: 7310528)
1. The significance of tumor marker assay in the staging of breast cancer. Assessment of ferritin and beta-HCG levels.
Micali B; Gioffrè Florio MA; Venuti A; Giorgianni G; Saitta FP
J Nucl Med Allied Sci; 1981; 25(3):65-70. PubMed ID: 7310528
[No Abstract] [Full Text] [Related]
2. [Significance of serum determination of beta-HCG in patients with breast cancer].
Tolino A; Di Serio C; Borruto Caracciolo G; Giamberini S; Giuliano A; Montemagno U
Minerva Ginecol; 1988 Nov; 40(11):629-33. PubMed ID: 2467228
[No Abstract] [Full Text] [Related]
3. [Ferritin in breast cancer].
Góźdź S; Słuszniak J; Bukowski J; Zagała A; Kowalski D; Korejba W; Banasińska E; Cheba L
Pol Tyg Lek; 1986 Sep; 41(35):1110-2. PubMed ID: 3797346
[No Abstract] [Full Text] [Related]
4. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of ferritin, CEA and AFP in patients operated on for carcinoma of the breast. Preliminary results].
Latteri M; Spinnato G; Pantuso G; Di Lisi G; Latteri S; Bellanca L; Latteri MT; Cirello B; Ciaccio M
Minerva Chir; 1987 May; 42(10):911-6. PubMed ID: 2442669
[No Abstract] [Full Text] [Related]
6. [Serum levels of 4 tumor-associated antigens in the evaluation of the spread of breast carcinoma].
Stefanović L; Kamenjicki E; Selir Z; Miljković L; Sterio B; Semnic R; Sljapić N
Med Pregl; 1984; 37(3-4):107-12. PubMed ID: 6208469
[No Abstract] [Full Text] [Related]
7. [Preliminary observations on the behavior of serum ferritin in female patients with breast cancer at various stages of the disease].
Dell'Anna B; Carnevali C; Crialesi Esposito G; Percudani M
Acta Biomed Ateneo Parmense; 1982; 53(3):147-51. PubMed ID: 6216702
[TBL] [Abstract][Full Text] [Related]
8. [Possibility of using tumor markers, pituitary gonadotropic hormones and prolactin in the diagnosis of breast cancer].
Korolev VI; Skliar SIu; Chebotareva ED; Akimova RN
Vopr Onkol; 1986; 32(11):55-9. PubMed ID: 3788082
[TBL] [Abstract][Full Text] [Related]
9. [Serum ferritin level in patients with breast cancer].
Rusinowska Z; Rozek-Lesiak K; Kokocińska D
Pol Tyg Lek; 1988 May; 43(22):706-8. PubMed ID: 3226979
[No Abstract] [Full Text] [Related]
10. [Relation of blood serum ferritin and ferritin-bearing lymphocytes in breast cancer].
Chernovskaia EM; Polevaia EB; Tuzhikova NK
Med Radiol (Mosk); 1986 Apr; 31(4):15-7. PubMed ID: 3959805
[TBL] [Abstract][Full Text] [Related]
11. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
Yang DC; Wang F; Elliott RL; Head JF
Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
[TBL] [Abstract][Full Text] [Related]
12. Serum ferritin and malignant tumours.
Jacobs A
Med Oncol Tumor Pharmacother; 1984; 1(3):149-56. PubMed ID: 6085815
[TBL] [Abstract][Full Text] [Related]
13. [The value of evaluating tumor markers: CA 15-3 and ferritin in blood serum of patients grouped as "high risk" for breast cancer].
Kokocińska D; Widala E; Donocik J; Nolewajka E
Przegl Lek; 1999; 56(10):664-7. PubMed ID: 10695382
[TBL] [Abstract][Full Text] [Related]
14. Significance of serum ferritin and lactate dehydrogenase in benign and malignant disease of breast.
Kher A; Moghe G; Deshpande A
Indian J Pathol Microbiol; 1997 Jul; 40(3):321-6. PubMed ID: 9354001
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
16. Breast engorgement, false positive pregnancy tests, and ectopic gonadotrophin production with bronchogenic carcinoma.
Snyder RW; Pickens PV; Kukora JS
Am Surg; 1995 Apr; 61(4):328-9. PubMed ID: 7893099
[TBL] [Abstract][Full Text] [Related]
17. Expression of beta-human chorionic gonadotropin (beta-hCG) in non-trophoblastic elements of transitional cell carcinoma of the bladder: possible relationship with the prognosis.
Bacchi CE; Coelho KI; Goldberg J
Rev Paul Med; 1993; 111(3):412-6. PubMed ID: 8108635
[TBL] [Abstract][Full Text] [Related]
18. Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man.
Yen SS; Llerena O; Little B; Pearson OH
J Clin Endocrinol Metab; 1968 Dec; 28(12):1763-7. PubMed ID: 5699949
[No Abstract] [Full Text] [Related]
19. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M
Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397
[TBL] [Abstract][Full Text] [Related]
20. Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.
Manders P; Tjan-Heijnen VC; Span PN; Grebenchtchikov N; Geurts-Moespot A; van Tienoven DT; Beex LV; Sweep FC
Cancer; 2004 Aug; 101(3):486-94. PubMed ID: 15274061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
